Fahrettin Covut MD

PubMed

• 1 citations
  Duvelisib for Critically Ill Patients With Coronavirus Disease 2019: An Investigator-Initiated, Randomized, Placebo-Controlled, Double-Blind Pilot Trial.
  Scott R Goldsmith, Fahrettin Covut, Mark Fiala, Zhifu Xiang, Zahid Iqbal
  Open Forum Infectious Diseases. 2023-11-01
• 8 citations
  Mitigating the risk of venous thromboembolism in patients with multiple myeloma receiving immunomodulatory-based therapy.
  Fahrettin Covut, Kristen M Sanfilippo
  Hematology. American Society of Hematology. Education Program. 2022-12-09
• 5 citations
  Bispecific Antibodies for the Treatment of Multiple Myeloma.
  Scott R Goldsmith, Shawn Streeter, Fahrettin Covut
  Current Hematologic Malignancy Reports. 2022-12-01

Lectures

• Impact of Previous Cancer Therapy on Outcome of Patients with Multiple Myeloma or Smoldering Disease 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Meta-Analyses of Clinical Trials Comparing the Progression Free Survival and Adverse Events in Treated Versus Observed Patients with Smoldering and Indolent Multiple M... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Risk of Intracerebral Hemorrhage with and without Anticoagulation in Patients with Brain Metastasis: The Cleveland Clinic Experience 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Direct oral anticoagulants (DOAC) versus warfarin and enoxaparin in ovarian vein thrombosis. 
  2019 ASCO Annual Meeting - 6/1/2019
• Feasibility and clinical impact of next-generation sequencing (NGS) in patients with stage IV or recurrent malignancies. 
  2019 ASCO Annual Meeting - 6/1/2019
• Outcomes Associated with Therapeutic Anticoagulation in Patients with Brain Metastasis 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Comparison of blast clearance in peripheral blood and day 14 bone marrow biopsy for evaluation of disease response after 7+3 induction in acute myeloid leukemia (AML). 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• Join now to see all